Clinical Trial Update: Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients

View source ↗

Summary

The clinical trial evaluating a cytokine in the cerebrospinal fluid of patients with multiple sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Multiple Sclerosis | Status: TERMINATED